
Glexia MV 2mg/500mg/0.2mg Tablet SR
Marketer
Glexia Pharma Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glexia MV 2mg/500mg/0.2mg Tablet SR
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled glucose levels; abrupt cessation can lead to hyperglycemia and increase the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a healthy diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with blood cell count and liver function tests as deemed necessary by your doctor, are recommended.
Primary Ingredients of Glexia MV 2mg/500mg/0.2mg Tablet SR
No text provided to rephrase.
Uses of Glexia MV 2mg/500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glexia MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glexia MV 2mg/500mg/0.2mg Tablet SR on an empty stomach.
Common Side effects of Glexia MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glexia MV 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glexia MV 2mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
How Glexia MV 2mg/500mg/0.2mg Tablet SR works:
Each Glexia MV SR tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glexia MV 2mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of Glexia MV 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glexica MV tablet (2mg/500mg/0.2mg) is likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Glexia MV 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Moreover, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glexia MV 2mg/500mg/0.2mg SR tablets cautiously. Dosage modification may be necessary. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically recommended; use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glexia MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Glexia MV 2mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glexia MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
